Beyond-the-headlines reporting on Myalgic Encephalomyelitis:
A 2010 Newport Pharmaceuticals Limited email obtained by CFS Central stated that the company ceased drug trials of Isoprinosine not because the drug was not effective—a preliminary study on ME/CFS patients indicated that it was efficacious—but solely because of the NICE Guidelines, which, stated the memo, “advocated non pharmaceutical intervention for the treatment of the condition.”
Isoprinosine has proved helpful for ... Read more>>
No comments:
Post a Comment